Auspex Pharmaceuticals, Inc. 4
4 · Auspex Pharmaceuticals, Inc. · Filed May 6, 2015
Insider Transaction Report
Form 4
Sarshar Sepehr
Director
Transactions
- Disposition from Tender
Common Stock
2015-05-05−242,574→ 0 total
Footnotes (2)
- [F1]Includes 16,260 shares of Common Stock that were received by the Reporting Person pursuant to a pro-rata distribution by Costa Verde Capital, LLC effective as of August 4, 2014.
- [F2]Disposed of pursuant to an Agreement and Plan of Merger (the "Merger Agreement"), dated March 29, 2015, among the Issuer, Teva Pharmaceuticals Industries Ltd. ("Parent"), and Aurum Merger Sub, Inc., a wholly-owned subsidiary of Parent ("Merger Sub") in exchange for a cash consideration of $101.00 per share, without interest, subject to any required withholding of taxes. Pursuant to the Merger Agreement, Merger Sub merged with and into the Issuer, with the Issuer continuing as the surviving corporation (the "Merger").